Send to:

Choose Destination
See comment in PubMed Commons below
Drug Deliv. 2015 May;22(3):328-34. doi: 10.3109/10717544.2014.894594. Epub 2014 Mar 10.

Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis.

Author information

  • 1Department of Pharmaceutics, Indo-Soviet Friendship College of Pharmacy, Nanomedicine Research Centre, Moga, Punjab, India.


The main aim of this study was to develop an effective carrier system containing Ag85A-loaded guar gum nanoparticles for oral vaccination against tuberculosis. Nanoparticles were prepared by Nanoprecipitation method. The developed particles with mean diameter 895.5 ± 14.73 nm and high antigen entrapment seem to be optimum for oral vaccine delivery. The acid protection assay, Peyer's patch uptake study and in-vitro antigen study confirmed that the developed formulations can protect the antigen from harsh gastric environment and can safely deliver the antigen to the intestinal region. In vivo studies data indicated that the developed nanocarriers can induce a strong mucosal as well as systemic immune response. Therefore, the experimental evidence suggests that guar-gum nanoparticle findings indicated that the guar gum nanoparticles can be utilized for safe and effective vaccine delivery via oral route.


Ag85A; guar gum; nanoparticles; oral vaccine; tuberculosis

[PubMed - in process]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Write to the Help Desk